Preview

Онкоурология

Расширенный поиск

Первичная зрелая тератома яичка: клинические, морфологические и иммуногистохимические факторы прогноза

https://doi.org/10.17650/1726-9776-2007-3-4-49-54

Полный текст:

Об авторах

К. Ольман
Университет Кельна
Германия

Подразделение онкоурологии, отделение урологии



А. Хайденрайх
Университет Кельна
Германия

Подразделение онкоурологии, отделение урологии



Список литературы

1. Mostofi F.K., Sesterhenn I.A. Pathology of germ cell tumors of testes. Prog Clin Biol Res 1985;203:1—34.

2. Read G., Stenning S.P., Cullen M.H. et al. Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party. J Clin Oncol 1992;10:1762—8.

3. Freedman L.S., Parkinson M.C., Jones W.G. et al. Histopathology in the prediction of of relapse of patients with stage I testicular treated by orchiectomy and alone. Lancet 1987;2:294—8.

4. Fung C.Y., Kalish L.A., Brodsky G.L. et al. Stage I nonsemimonatous germ cell tumor: prediction of metastatic potential by primary histopathology. J Clin Oncol 1988;6:1467—73.

5. Klepp O., Olsson A.M., Henrickson H. et al. Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. J Clin Oncol 1990;8:509—18.

6. Leibovitch I., Foster R.S., Ulbright T.M., Donohue J.P. Adult primary pure teratoma of the testis. Cancer 1995;75:2244—50.

7. Simmonds P.D., Lee A.H.S., Theaker J.M. et al. Primary pure teratoma of the testis. J Urol 1996;155:939—42.

8. Heidenreich A., Moul J.W., McLeod D.G. et al. The role of retroperitoneal lymphadenectomy in mature teratoma of the testis. J Urol 1997;157:160—3.

9. Rabbani F., Farivar-Mohseni H., Leon A. et al. Clinical outcome after retroperitoneal lymphadenectomy of patients with pure testicular teratoma. Urology 2003;62:1092—6.

10. Sesterhenn I.A., Weiss R.B., Mostofi F.K. et al. Prognosis and other clinical correlates of pathologic review in stage I and stage II testicular carcinoma: a report from the testicular cancer intergroup study. J Clin Oncol 1992;10:69—78.

11. Moul J.W., McCarthy W.F., Fernandez E.B., Sesterhenn I.A. Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer. Cancer Res 1994;54(2):362—4.

12. Heidenreich A., Sesterhenn I.A., Mostofi K.F., Moul J.W. Prognostic risk factors to predict patients at low risk and at high risk for metastasis in clinical stage I nonseminomatous germ cell tumors. Cancer 1998;82:1002—11.

13. Sella A., El Naggar A., Ro J.Y. et al. Evidence of malignant features in hitsologically mature teratoma. J Urol 1991;146(4):1025—8.

14. Baniel J., Foster R.S., Gonin R. et al. Late relapse of testicular cancer. J Clin Oncol 1995;13:1170—6.

15. Fung C.Y., Kalish L.A., Brodsky G.L. et al. Stage I nonseminomatous germ cell tumor: prediction of metastatic potential by primary histopathology. J Clin Oncol 1988;6:1467—73.

16. Andre F., Fizazi K., Culine S. et al. The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients. Eur J Cancer 2000;36:1389—94.

17. Sturgeon J.F., Jewett M.A., Alison R.E. et al. Surveillance after orchiectomy for patients with clinical stage I nonseminomatous germ cell tumors. J Clin Oncol 1992;10:564—8.

18. Stevens M.J., Norman A.R., Fisher C. et al. Prognosis of testicular teratoma differentiated. Brit J Urol 1994;73:701—8.

19. Borge N., Fossa S.D., Ous S. et al. Late recurrence of testicular cancer. J Clin Oncol 1988;6:1248—54.

20. Nicolai N., Pizzocaro G. Ten year follow-up of a surveillance study in clinical stage I nonseminomatous germ cell tumors of the testis. J Urol 1995;153(Suppl):245A:abstr #65.

21. Baniel J., Foster R.S., Rowland R.G. et al. Complications of primary retroperitoneal lymph node dissection. J Urol 1994;152:424—6.

22. Heidenreich A., Albers P., Hartmann M. et al. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group. J Urol 2003;169:1710—4.

23. Rabbani F., Gleave M.E., Coppin C.M. et al. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy: case for primary retroperitoneal node dissection in stage IIB germ cell tumors with teratomatous elements. Cancer 1996;78:480—6.

24. Beck S.D.W., Foster R.S., Bihrle R. et al. Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in postchemotherapy nonseminomatous testis cancer. J Urol 2002;168:1402—4.

25. Heidenreich A., Seger M., Schrader A.J. et al. Surgical considerations in residual tumor resection following chemotherapy for advanced testicular cancer. Eur Urol 2004;(Suppl 3):161; abstr #632.

26. Albers P., Weissbach L., Krege S. et al. for the German Testicular Cancer Study Group. Prediction of Necrosis after chemotherapy of advanced germ cell tumors: results of prospective multicenter trial of German Testicular Cancer Study Group. J Urol 2004;171(5):1835—8.

27. Steyerberg E.W., Keizer H.J., Fossa S.D. et al. Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. J Clin Oncol 1995;13:1177—87.

28. Oldenburg J., Alsen G.C., Lien H.H. et al. Postchemotherapy retroperitoneal surgery for nonseminomatous germ cell tumours: recommendations for patient selection. J Clin Oncol 2003;21:3310—5.

29. Patel M.I., Beck S., Bosl G. et al. Histology of good risk non-seminomatous germ cell tumor (NSGCT) patients following retroperitoneal lymph node dissection (PC-RPLND) after four cycles of etoposide and cisplatin (Epx4). J Urol 2003;169(Suppl):176; abstr #681.

30. Fossa S.D., Qvist H., Stenwig A.E. et al. Is postchemotherapyretroperitoneal surgery necessary in patients with nonseminonatous testicular cancer and minimal residual tumor masses? J Clin Oncol 1992;10:569—74.


Для цитирования:


Ольман К., Хайденрайх А. Первичная зрелая тератома яичка: клинические, морфологические и иммуногистохимические факторы прогноза. Онкоурология. 2007;3(4):49-54. https://doi.org/10.17650/1726-9776-2007-3-4-49-54

For citation:


Olman K., Keinderreich A. Primary mature teratoma of the testis: clinical, morphological, and immnohistochemical predictors. Cancer Urology. 2007;3(4):49-54. (In Russ.) https://doi.org/10.17650/1726-9776-2007-3-4-49-54

Просмотров: 25


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)
X